JSB Market Research: Asthma Therapeutics Market to 2019

Scope
The report assesses the current asthma market, and forecasts market trends to 2019, analyzing
key drivers and barriers. The areas covered include the following -
A disease introduction, which defines the disease, including symptoms, diagnosis and treatment
Analysis of the landscape of the asthma market, including a comparison of the efficacy and
safety of the most prominent brands
Detailed analysis of the asthma pipeline, including, among other parameters, details of drug
distribution by phase, molecule type and mechanism of action. The asthma clinical trial
landscape is then analyzed, with a particular emphasis on failure rates across phases as well as
trends in clinical trial size and duration, and by mechanism of action. This section also includes
single-product forecasts for the most promising pipeline drugs.
An in-depth forecasting model for the asthma market, which considers the current marketed
therapies, in addition to the potential market entry of new products. The model consists of a
projected outcome, with high and low variance results, depending on the potential
performance of pipeline therapies.
Analysis of strategic consolidations within the asthma indication, including co-development and
licensing agreements
An overview of the drivers and barriers for the asthma market
Reasons to buy
Primarily, the report will enable clients to establish a strong understanding of the asthma
indication, helping to identify and understand market opportunities and the emerging
competitive environment. It will also enable you to -
Understand the asthma pipeline and the factors that indicate that it is becoming more
innovative. This is highlighted by the presence of numerous biologics in the pipeline, which look
set to have a major impact upon the asthma market.
Observe detailed profiles for promising pipeline products, including revenue forecasts, and gain
insights into how they are likely to compete in the market and who their main competitors will
be.
Follow the trends in asthma clinical trial size and duration in relation to industry averages. In
addition, the report will enable you to assess the potential risk of future developmental
programs for asthma therapeutics, depending on the mechanism of action, by considering the
recorded clinical trial failure rates.
Observe the potential growth patterns expected for the asthma market over the forecast
period, and identify which countries are expected to contribute the most to this growth.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/